← FDA DRUG APPROVALS

FDA ANDA · ANDA065352

CEFADROXIL

Sponsor: AUROBINDO PHARMA

APPLICATION
ANDA065352
TYPE
ANDA
ORIGINAL APPROVAL
2007-01-25
LATEST ACTION
2014-04-18
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

CEFADROXILPrescription
CEFADROXIL/CEFADROXIL HEMIHYDRATE EQ 500MG BASE · CAPSULE · ORAL

Approval history

2014-04-18Labeling · Supplement 4 · standardAP
2007-11-08Labeling · Supplement 1AP
2007-01-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →